trending Market Intelligence /marketintelligence/en/news-insights/trending/biGlxpwNGR4WP_I8Ad-Y6Q2 content esgSubNav
In This List

Apellis Pharmaceuticals names CFO

Video

According to Market Intelligence, December 2022

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022


Apellis Pharmaceuticals names CFO

Apellis Pharmaceuticals Inc. appointed Timothy Sullivan to serve as CFO.

Sullivan was most recently an observer on Apellis' board for nearly three years while he was a partner at venture capital firm AJU IB Investment, where he led the firm's investments in life sciences companies.